SC 13D Filing

Company

Immunome Inc.

Filed

October 12, 2023

Accession Number

0000895345-23-000577

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →